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Abstract
Eleven affected members of a large German-American family segregating recessively inherited,
congenital, non-syndromic sensorineural hearing loss (SNHL) were found to be homozygous for
the common 35delG mutation of GJB2, the gene encoding the gap junction protein Connexin 26.
Surprisingly, four additional family members with bilateral profound SNHL carried only a single
35delG mutation. Previously, we demonstrated reduced expression of both GJB2 and GJB6
mRNA from the allele carried in trans with that bearing the 35delG mutation in these four
persons. Using array comparative genome hybridization (arrayCGH), we have now identified on
this allele a deletion of 131.4 kb whose proximal breakpoint lies more than 100 kb upstream of the
transcriptional start sites of GJB2 and GJB6. This deletion, del(chr13:19,837,344-19,968,698),
segregates as a completely penetrant DFNB1 allele in this family. It is not present in 528 persons
with SNHL and monoallelic mutation of GJB2 or GJB6, nor have we identified any other
candidate pathogenic copy number variation by arrayCGH in a subset of 10 such persons.
Characterization of distant GJB2/GJB6 cis-regulatory regions evidenced by this allele may be
required to find the ‘missing’ DFNB1 mutations that are believed to exist.
Keywords
Connexin 26; connexin 30; DFNB1; gene expression regulation; GJB2; GJB6; sensorineural
hearing loss; sequence deletion
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INTRODUCTION
Mutation in the Connexin 26 (Cx26) gap junction protein-encoding gene GJB2 (MIM
121011) is the most commonly identified cause of congenital, recessively inherited,
sensorineural nonsyndromic hearing loss (DFNB1A [MIM 220290])(1-2). In the inner ear,
Cx26 and Cx30 (encoded by GJB6 [MIM 604418], which lies 30 kb telomeric to GJB2 on
human chromosome 13) are expressed in non-sensory cells of the organ of Corti and in cells
of the spiral ligament and stria vascularis. Cx26/Cx30 cochlear gap junctions have been
implicated in maintenance of K+ homeostasis in the inner ear(3-4). However, more recent
studies point to a complex suite of functions for gap-junctional networks throughout the
cochlea involving participation of second-messengers and including generation of the
endocochlear potential(5-7). This intricate set of roles depends on a varied distribution and
composition of connexon hemichannels and gap junctions throughout the epithelial
supporting cell and connective tissue gap-junctional networks of the cochlea(8-12), therefore
requiring tight regulation of expression of GJB2 and GJB6.
Although more than 200 mutations of GJB2, two deletions involving GJB6 (DFNB1B [MIM
612645]), and one deletion encompassing both GJB2 and GJB6 constitute the reported set of
DFNB1 mutations(1, 13-15), population screening commonly yields an excess of
individuals with hearing loss who carry only a single identified GJB2 mutation or DFNB1
deletion(16). This finding strongly suggests that additional mutations that lie outside of the
proximal promoter and transcribed regions of GJB2 remain to be identified. Here we
identify a novel 131.4 kb deletion, distant from the transcriptional start sites of both GJB2
and GJB6, that segregates as a DFNB1 allele in the extended family in which it is found, and
that also segregates with reduced expression of either GJB2 or GJB6 mRNA in four family
members assayed. This finding has relevance for the identification of distant GJB2 and
GJB6 cis-regulatory elements, as sequence variations within these elements may prove to
constitute the bulk of ‘missing’ GJB2 mutations in DFNB1 hearing loss.
MATERIALS AND METHODS
Human subjects
Participating MSU-DF5 subjects were ascertained through the Oyer Speech-Language-
Hearing Clinic within the Department of Communicative Sciences and Disorders at
Michigan State University. Audiologic examination of family members included otoscopy,
tympanometry, and pure-tone and air- and bone-conduction thresholds. DNA was isolated
from blood, saliva, or cheek swabs. Genealogical information was collated from family
histories and from publicly available records. Additional subjects were ascertained from
hearing loss referrals to the Molecular Otolaryngology Research Laboratories at the
University of Iowa. Written informed consent for genetic and audiological testing was
obtained from all participants or from the parents of minors. The Michigan State University
Institutional Review Board and the University of Iowa Human Subjects Committee
approved all procedures.
Array Comparative Genome Hybridization
To examine potential cis-regulatory regions for mutation, we looked first for copy number
variants by array comparative genome hybridization (arrayCGH) using a finely-tiled CGH
microarray designed and manufactured by Nimblegen Systems. Included on the array were
384,000 overlapping oligomeric probes of 45-80 nucleotides in length from regions of non-
repetitive sequence on human chromosome 13q11-12, spanning ~6.5 Mb from the most
centromeric annotated sequence at chr13:18,000,000 to chr13:24,500,000 (Build 36.1). We
provided Nimblegen with DNA from MSU-DF5-20, one of the four deaf family members
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with monoallelic mutation of GJB2. Nimblegen carried out the labeling and hybridizations
on MSU-DF5-20 as well as on DNA from 10 additional unrelated GJB2 heterozygotes with
severe-to-profound NSHL. Identification of the breakpoints of del(chr.13:
19,837,344-19,968,698) was done by bidirectional Sanger sequencing of the 628 bp PCR
product amplified with primers flanking the region of copy number loss (see next section).
Confirmation of regions of deletion and duplication in the additional GJB2 heterozygotes
and screening in 160 CEPH controls was done by PCR with flanking primers; these products
were not sequenced for breakpoint identification.
Deletion screening by PCR assay
To screen for del(chr.13: 19,837,344-19,968,698), we designed a 2-product multiplex PCR
assay. Two primers (5′-TGGGACCAGGTCTGTTGTT-3′ and 5′-
ATTGCGACTTGCTTTTCGTT) flank the deletion breakpoint and amplify a 628 bp
product from genomic DNA bearing the deletion; the second primer pair (5′-
GCAGCCATCTCATGGTCTCT-3′ and 5′-CCAACACAATTGGGTCACTCT-3′) amplifies
an 836 bp product from sequence within the deleted interval. In a 20 ul reaction containing
1.5 mM MgCl2, 25 uM primer, 0.2 mM dNTP, and 0.5 U Taq polymerase, genomic DNA
(10-40 ng) was denatured for 5 min at 94°C, followed by 35 cycles of 94°C for 30 s, 66°C
for 30 s, and 72°C for 1 min, with a final extension at 72°C for 7 min. Products were
resolved on a 1% agarose gel containing 0.3 ug/ml ethidium bromide. DNA from 220 MSU-
DF5 family members, 160 CEPH controls, and 528 patients with hearing loss who are
heterozygous for a known GJB2/GJB6 mutation was assayed.
RESULTS
Identification of del(chr13:19,837,344-19,968,698) in an extended family segregating DFNB1
hearing loss
Figure 1 shows a small portion of the pedigree of MSU-DF5, an extended family descended
from a founder community of 500 German-Catholic emigrant families who settled in
Michigan in the 19th century. Eleven living family members with hearing loss are known to
be homozygous for the common European founder mutation of GJB2, 35delG (only one of
those individuals is included in Fig. 1). Unexpectedly, four other family members with
bilateral profound SNHL carry only a single 35delG mutation but share the same haplotype
on their non-35delG chromosome. Previously, we documented allele-specific reduction of
GJB2 and GJB6 expression from this allele in buccal cells from four heterozygous
individuals (two deaf, with 35delG in trans; two hearing, with normal GJB2 and GJB6
alleles in trans)(17). Sequencing of the coding regions, 5′ and 3′ UTRs, proximal promoter
regions, and splice sites of both GJB2 and GJB6, as well as several kilobases of sequence
upstream of GJB2 failed to identify any other sequence variant unique to this low-expression
allele.
A single copy region identified by arrayCGH (Fig. 2A) was confirmed by PCR and
sequencing (Fig. 2B) to be a deletion of 131.4 kb that is carried in trans with the 35delG
mutation in the four deaf 35delG heterozygotes. The proximal breakpoint of this deletion is
in intergenic sequence at chr13:19,837,344 within a simple repeat of (TG)21, leaving 9 TG
dinucleotides intact on the deleted chromosome. The distal breakpoint occurs at
chr13:19,968,698 within a LINE element located in the second intron of CRYL1. The
sequence flanking the breakpoints does not clearly indicate a mechanism by which the
deletion was generated. No homology exists between the sequences including and
immediately adjacent to the breakpoints. The existence of only a single base pair of
microhomology at the breakpoint junction is consistent with nonhomologous end joining
(NHEJ) and double-strand break (DSB) repair.
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Del(chr13:19,837,344-19,968,698) segregates as a completely penetrant DFNB1 allele and
is >300 years old
Of the 220 MSU-DF5 family members tested, 27 are heterozygous and none are
homozygous for the deletion. The deletion is present on the chromosomes from which
reduced expression of GJB2 and GJB6 message was documented (in MSU-DF5-20, -65,
-67, and -70), and in all four deaf 35delG heterozygotes, indicating that the deletion-bearing
chromosome segregates in this pedigree as a completely penetrant recessive DFNB1 allele
(Figure 1). This deletion was not identified in 160 CEPH controls.
Under the assumption of identity-by-descent, and by choosing the least number of meioses
to relate carriers, the deletion chromosome can be traced back to four individuals born in
Germany between 1702 and 1716, all equally likely to have contributed this allele to the
MSU-DF5 pedigree. Although the deletion allele is thus at least 300 years old and may exist
outside of this pedigree, it has not been identified among 528 persons from the United
States, Brazil, Iran, and several European countries with hearing loss who are heterozygous
for a single GJB2/GJB6 mutation (Table 1).
Assessment of 35delG-heterozygotes with SNHL for incidence of pathogenic copy number
variation across the DFNB1 locus
To determine if deletions may constitute a frequent mechanism for DFNB1 deafness, we
performed arrayCGH on DNA from 10 unrelated 35delG-heterozygous patients with severe
to profound SNHL. We identified copy number variants (CNVs) across the region (Table 2),
including 5 deletions ranging in size from 130 bp to 450 bp, and 3 duplications between 65
bp and 960 bp in size. Three regions were associated with either duplication or deletion.
CNVs were confirmed by PCR with flanking primers, although the breakpoints were not
precisely identified. All of these CNVs were present in 160 CEPH controls at frequencies
higher than 20%.
DISCUSSION
Of the nearly 100 loci mapped for human inherited nonsyndromic hearing loss since the
early 1990s, 46 genes have been identified with sufficient evidence to establish causation.
Mutations in two of these genes, GJB2 and SLC26A4, cause a significant proportion of
hearing loss globally, with loss-of-function mutations of GJB2 estimated to be responsible
for more than half of all recessively inherited NSHL in developed countries (1). This
knowledge has changed the medical evaluation of families segregating presumed autosomal
recessive NSHL and has made accurate genetic counseling, recurrence chance estimation,
phenotype-genotype correlations and prognosis for progression of hearing loss possible
when two mutant alleles of GJB2 are identified. It is widely accepted that unidentified
mutations of GJB2 exist that are cis-regulatory in nature. Deletion alleles that abrogate
expression of GJB2 without disrupting the gene sequence are important for identifying
candidate cis-regulatory regions for mutation analysis.
The deletion we have described, del(chr13:19,837,344-19,968,698), represents the fourth
DFNB1 deletion allele, and the third in which GJB2 is left intact. Del(GJB6-D13S1830)(13,
18-19) and del(GJB6-D13S1854)(14), deletions of 309 kb and 232 kb, respectively, truncate
GJB6 and extend telomerically (Figure 2C). Lerer et al(18) showed GJB2 expression from
both alleles in lymphocytes from a patient heterozygous for del(GJB6-D13S1830) and on
this basis suggested that a digenic interaction between GJB2 and GJB6 may be responsible
for the hearing loss in these individuals. Our allele-specific expression assay results on
del(chr13:19,837,344-19,968,698), which suggest otherwise, were consistently replicated
using stratified epithelial cell-derived cDNA from buccal swabs while assays of
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lymphocyte-derived cDNA from the same individuals gave inconsistent results (data not
shown). This discrepancy may indicate that regulation of GJB2 and GJB6 differs with tissue
type, and that expression assayed in lymphocytes may not be relevant to expression in
cochlear cells.
Common et al(20) also demonstrated loss of normal Cx26 expression from the deletion-
bearing allele in stratified epithelial skin cells in an individual with hearing loss and a
35delG/del(GJB6-D13S1830) genotype. These results are consistent with hypotheses of
complex cis-regulation of GJB2 and loss of an important GJB2 regulatory element as a
result of these deletions. Qualitative loss of GJB2 expression from alleles bearing del(GJB6-
D13S1830) in compound heterozygosity with GJB2 mutations/variants E47X, M34T, and
V27I/E114G has since been demonstrated in three individuals(21), further supporting this
mechanism of action.
Feldmann et al(15) have provided additional evidence against the GJB2/GJB6 digenic
hypothesis. They have documented a >920 kb deletion encompassing GJB2, GJB6, GJA3
and several other genes that is present in trans with the V84M mutation of GJB2 in a deaf
individual. Three other persons with normal hearing in this pedigree carry this contiguous
gene deletion, indicating that loss of single copies of GJB2 and GJB6, per se, cannot explain
the pathogenicity of the two GJB6-truncating deletion alleles, del(GJB6-D13S1830) and del
(GJB6-D13S1854).
Del(chr13:19,837,344-19,968,698) is of particular interest as it leaves both GJB2 and GJB6
completely intact, has a proximal breakpoint substantially farther from GJB2 than the GJB6-
truncating DFNB1 deletion alleles, and segregates with reduced expression of both GJB2
and GJB6. These findings suggest that time- and tissue-specific enhancer elements for both
genes may lie a considerable distance upstream, and/or that a locus control region exists for
these two genes. We hypothesize a similar mechanism of pathogenesis for all three deletion
alleles that involves, in addition to loss or reduction in expression of GJB6, the loss of a
critical cis-regulatory element for GJB2 located within the common 95.4 kb genomic
interval that is deleted in all three alleles. Sequence conservation between species is one
metric by which candidate noncoding regulatory DNA may be identified. Human-mouse
sequence conservation and rank VISTA (rVISTA) calculations of potential regulatory
function(22-23) (Figure 2D, reproduced from the VISTA browser) show numerous
candidate regulatory elements within this interval.
Since we found del(chr13:19,837,344-19,968,698) in only one extended family, as an
alternate, less parsimonious hypothesis, del(chr13:19,837,344-19,968,698) could be in
linkage disequilibrium with a pathogenic single nucleotide substitution or other undetected
DNA lesion closer to both GJB2 and GJB6 that disrupts cis-regulatory function of both
genes coordinately. This possibility also permits a common mechanism of pathogenesis of
the three deletion alleles which leave GJB2 intact, and accommodates the evidence of loss of
GJB2/Cx26 expression observed from the del(GJB6/D13S1830) allele by Rodrigues-Paris et
al(21) and by Common et al(20).
The identification of additional deletions is possible with the increasing accessibility of
arrayCGH and other techniques to assess CNV. Although patients with severe-to-profound
hearing loss and monoallelic GJB2 mutation are candidates for pathogenic CNV, our
findings from 10 such patients suggest that while CNV is common, identifying the
regulatory regions may require an alternative approach such as enhancer-reporter assays.
The CNVs we found among our 10 patients were all found among CEPH controls at
frequencies higher than 20%.
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Sequence variation within regulatory elements can give rise to allele-specific quantitative
differences in expression of message that may yield phenotypic variation(24-25). Variability
in degree of hearing loss is a well-documented feature of GJB2 deafness, even among
persons with biallelic null (protein-truncating) mutations that completely abolish Cx26
protein expression(16, 26). No modifier genes have yet been identified to explain this
phenotypic variability(27). We hypothesize that sequence variation in cis that regulates
GJB6 expression from a distance may be partially responsible for some of this variability.
In summary, our studies of del(chr13:19,837,344-19,968,698) support the presence of
distant cis-regulation of GJB2 and substantially reduce the span of chromosome 13 that is
most strongly implicated in this function. We also provide the first evidence of distant cis-
regulation of GJB6. Additional efforts to elucidate and characterize distant GJB2 and GJB6
cis-regulatory regions are clearly warranted.
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Figure 1.
The MSU-DF5 sub-pedigree shown here includes the four profoundly deaf family members
who are compound heterozygotes for del(chr13:19,837,344-19,968,698) (green shading) and
for the 35delG mutation of GJB2 (blue shading) which segregates within this family. Of the
220 family members screened, twenty-seven unaffected persons are heterozygous for the
deletion and are negative for 35delG; they are shown here, although a number of unaffected
siblings who are negative for both mutations are not. The most recent common ancestors of
the known carriers of del(chr13:19,837,344-19,968,698) were born in the early eighteenth
century in northern Europe. We previously documented reduced expression of GJB2 in three
persons (red arrows) and GJB6 in one person (yellow arrow) from the allele now known to
bear del(chr13:19,837,344-19,968,698).
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Figure 2.
Characterization of novel DFNB1 deletion allele del(chr13:19,837,344-19,968,698). (A)
Custom arrayCGH across a 6.5 Mb region of human chromosome 13 indicates a region of
single copy number loss in MSU-DF5-20.
(B) Del(chr13:19,837,344-19,968,698) breakpoint junctional sequence amplified from
MSU-DF5-20 DNA and aligned with human genome reference sequence (Build 36.1) shows
a single basepair of microhomology at the breakpoint.
(C) Del(chr13:19,837,344-19,968,698) overlaps with DFNB1 deletions del(GJB6-
D13S1830) and del(GJB6-D13S1854) over a 95.4 kb interval upstream of the transcriptional
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start sites (indicated by right-angled arrows) of GJB2 and GJB6. CRYL1 is also shown.
Exons of all genes are indicated by vertical lines.
(D) Upper VISTA track shows sequence conservation between human (March 2006) and
mouse (July 2007) genomes over the 95.4 kb interval common deletion interval indicated in
Fig. 2C; pink-colored peaks represent regions of 100+ bp of non-coding sequences
conserved at ≥70% identity. Lower track shows rankVISTA (rVISTA) predictions
(−log10[P-value]) of potential regulatory function based on multispecies sequence
conservation combined with identification of transcription factor binding sites
(http://genome.lbl.gov/vista/index.shtml).
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Table 1
Number of affected individuals with monoallelic GJB2/GJB6 mutation screened for
del(chr13:19,837,344-19,968,698).
Laboratory (Investigators) N Reported ethnicity or nationality
USA/Iowa (Smith/Azaiez) 55
USA/Virginia (Pandya) 132 96 caucasian, 4 black, 25 hispanic, 7 other
Spain (del Castillo) 50
Brazil (Sartorato/da Silva Costa) 40
France (Le Marechal) 41
Netherlands (Kremer/Hoefsloot) 27
Germany/Freiburg (Birkenhäger) 62
Germany/Koln (Bolz/Kubisch) 10
Germany/Mainz (Haaf/Schneider) 31 23 German, 5 Turkish, 2 Moroccan, 1 Spanish
Italy (Murgia) 22
Belgium (Van Camp/Wuyts) 58 40 Belgian, 18 Iranian
Total 528
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Table 2
List of CNVs in the DFNB1 region
Position* Variation Length* (bp)
Chr13:19686728-19686792 dup 65
Chr13:19691120-19691940 dup 820
Chr13:19722020-19722070 del/dup 50
Chr13:19749870-19750200 del 340
Chr13:19768000-19768130 del 130
Chr13:19818780-19819200 del 420
Chr13:19835210-19835420 del/dup 200
Chr13:19863060-19864020 del/dup 960
Chr13:19934100-19934550 del 450
Chr13:19969740-19970700 dup 960
Chr13:19974330-19974480 del 150
*
Length and position are approximate; del: deletion; dup; duplication
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